Although very little data are available regarding the involvement of neuromedins in the development of Alzheimer’s disease, it is noteworthy that mild cognitive impairment can be associated with increased levels of neuromedin activity [475], despite the fact that neuromedins themselves appear to be intrinsically neuroprotective [476]. The gene discussed is NMS; the disease is early-onset autosomal dominant Alzheimer disease.